Jupiter Neurosciences, Common Stock Five Year Return

JUNS Stock  USD 10.95  1.22  12.54%   
Jupiter Neurosciences, Common fundamentals help investors to digest information that contributes to Jupiter Neurosciences,'s financial success or failures. It also enables traders to predict the movement of Jupiter Stock. The fundamental analysis module provides a way to measure Jupiter Neurosciences,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Jupiter Neurosciences, stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Jupiter Neurosciences, Common Company Five Year Return Analysis

Jupiter Neurosciences,'s Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.

Five Year Return

 = 

(Mean of Monthly Returns - 1)

X

100%

More About Five Year Return | All Equity Analysis

Jupiter Five Year Return Driver Correlations

Understanding the fundamental principles of building solid financial models for Jupiter Neurosciences, is extremely important. It helps to project a fair market value of Jupiter Stock properly, considering its historical fundamentals such as Five Year Return. Since Jupiter Neurosciences,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Jupiter Neurosciences,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Jupiter Neurosciences,'s interrelated accounts and indicators.
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
Competition

Jupiter Return On Tangible Assets

Return On Tangible Assets

(33.8)

At this time, Jupiter Neurosciences,'s Return On Tangible Assets are comparatively stable compared to the past year.
According to the company disclosure, Jupiter Neurosciences, Common has a Five Year Return of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Biotechnology (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Jupiter Five Year Return Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Jupiter Neurosciences,'s direct or indirect competition against its Five Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Jupiter Neurosciences, could also be used in its relative valuation, which is a method of valuing Jupiter Neurosciences, by comparing valuation metrics of similar companies.
Jupiter Neurosciences, is currently under evaluation in five year return category among its peers.

Jupiter Fundamentals

About Jupiter Neurosciences, Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Jupiter Neurosciences, Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jupiter Neurosciences, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jupiter Neurosciences, Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Jupiter Stock Analysis

When running Jupiter Neurosciences,'s price analysis, check to measure Jupiter Neurosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jupiter Neurosciences, is operating at the current time. Most of Jupiter Neurosciences,'s value examination focuses on studying past and present price action to predict the probability of Jupiter Neurosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jupiter Neurosciences,'s price. Additionally, you may evaluate how the addition of Jupiter Neurosciences, to your portfolios can decrease your overall portfolio volatility.